Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Artificial Tendons and Ligaments Market by Application (Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Others), by End users (Hospitals and Clinics, ASCs): Global Opportunity Analysis and Industry Forecast, 2021 - 2031

A10245

Pages: 240

Charts: 55

Tables: 115

Artificial Tendons And Ligaments Market Research, 2031

The global Artificial Tendons And Ligaments Market Size was valued at $64.3 million in 2021 and is projected to reach $165.7 million by 2031, growing at a CAGR of 10.1% from 2022 to 2031. Artificial tendons and ligaments are biological implants that are used for the reconstruction of ruptured tendons and ligaments. Tendons are cable-like tissues that connect muscles to bones. Ligament tissue helps to keep the bones in a proper position at the joints and also helps in the movement of bones. Ligaments are typically used to link two bones, especially in the joints. They support the joint or hold the ends of two bones together like strong, firmly fastened straps or ropes. This prevents the bones of the joint from twiddling or moving too far apart and becoming dislocated. There are some joints that are mostly supported by tendons and ligaments, including shoulder, elbow, knee, spine, hip, and ankle joints. Artificial tendons and ligaments are biological implants that are used for the reconstruction of ruptured tendons and ligaments. Tendons are cable-like tissues that connect muscles to bones. Ligament tissue helps to keep the bones in a proper position at the joints and also helps in the movement of bones. Ligaments are typically used to link two bones, especially in the joints. They support the joint or hold the ends of two bones together like strong, firmly fastened straps or ropes. This prevents the bones of the joint from twiddling or moving too far apart and becoming dislocated. There are some joints that are mostly supported by tendons and ligaments, including shoulder, elbow, knee, spine, hip, and ankle joints.

[COVIDIMPACTSTATEMENT]

Get more information on this report: Request Sample Pages

Artificial tendons and ligaments are widely used for replacing ruptured or damaged tendons and ligaments in arthritis, sports injuries, and severe tendonitis. The artificial tendons and ligaments market has witnessed growth, owing to an upsurge in the incidence of accidents and rise in the prevalence of osteoporosis cases and tendonitis.

According to the International Osteoporosis Foundation, approximately 8.9 million fractures were reported in 2020. Moreover, as per the World Health Organization, in 2020, osteoporosis affected 6.3% of men and 21.2% of women aged above 50. Hence, the growing burden of osteoporosis cases has increased the use of implant devices, thus boosting the growth of the artificial tendons and ligaments market.

According to the International Osteoporosis Federation, due to the higher availability of dual-energy X-ray absorptiometry instruments for the diagnosis of osteoporosis and the resulting increased detection of osteoporosis, there will be a surge in the usage of artificial tendons and ligaments. Furthermore, an increase in the number of product or procedure approvals is expected to provide remunerative opportunities for the expansion of the global Artificial Tendons And Ligaments Market Share during the Artificial Tendons And Ligaments Market Forecast period.

In addition, an increase in incidences of sports-related injuries and accidents propels the demand for artificial tendons and ligaments. For instance, according to the National Safety Council (NSC), in 2020, it was observed that bicycling accounted for about 426,000 injuries in the U.S., the most of any category of sports and recreation. Hence, an increase in incidents of sports injuries affecting joints where replacement surgery is suggested contributes to the Artificial Tendons And Ligaments Market Growth. In addition, according to Arthritis Statistics, the global RA network, in 2022, it is estimated that approximately 350 million people are living with arthritis globally. Also, as per the information provided by Statista, in 2020, the number of knee replacement surgeries performed in Switzerland was 260 per 100,000 inhabitants. Thus, the globally increasing prevalence of severe osteoarthritis or rheumatoid arthritis and the rising number of knee replacement surgeries drive the growth of the artificial tendons and ligament market.

The sales of artificial tendons and ligaments have witnessed hindrances, owing to a lack of skilled professionals in emerging and less developed countries and stricter regulatory standards. In addition, the high cost of artificial tendons and ligaments is the key factor restraining the market. Due to these factors, the sales of premium artificial tendons and ligaments are low. Conversely, the introduction of new artificial tendons and ligaments in developing nations is anticipated to offer remunerative opportunities for the expansion of the global market during the forecast period.

Furthermore, the healthcare business in developing nations is predicted to grow significantly as a result of various reasons, including increased investment in both the public and private sectors, a rise in tendon and ligament-related diseases, and population expansion. An increase in healthcare spending is also expected to promote the expansion of the healthcare business, which, in turn, is expected to fuel product demand.

The artificial tendons and ligaments market is segmented on the basis of application, end user, and region. On the basis of application, the market is classified into knee injuries, shoulder injuries, foot & ankle injuries, and others. Depending on the end user, it is segmented into hospitals & clinics, and ambulatory surgery centers.

The artificial tendons market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

Segment Review

By Application

On the basis of the application of artificial tendons and ligaments, the knee injuries segment generated maximum revenue in 2021, and is expected to witness the highest CAGR during the forecast period, owing to a rise in physical exercise among children and adults, an increase in interest of professional sports, and increase in a number of athletes that are prone to knee injuries.

[APPLICATIONGRAPH]

By End User

On the basis of end users, the hospitals & clinics segment was the highest revenue contributor to the market in 2021, owing to an increase in the number of patient admissions, well-resourced diagnostic rooms, and higher buying power.

[ENDUSERSGRAPH]

By Region

On the basis of region, North America dominated the Artificial Tendons And Ligaments Market Size in 2021, owing to a rise in the number of tendon and ligaments injury cases, the presence of key players, robust healthcare infrastructure, and the availability of approved therapeutics with higher adoption of artificial tendon and ligament products.

[REGIONGRAPH]

Some of the major companies that operate in the global Artificial Tendons And Ligaments Market Share are Artelon, Arthrex, Inc., Corin Group, Enovis, Exactech, Inc., FX-Global, Inc., Group FH Communication, Integra Lifesciences, Neoligaments, and Stryker Corporation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the artificial tendons and ligaments market analysis from 2021 to 2031 to identify the prevailing artificial tendons and ligaments market opportunity.
  • Artificial Tendons And Ligaments Industry research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
  • An in-depth analysis of the Artificial Ligaments Market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the Artificial Tendons And Ligaments Industry players.
  • The report includes an analysis of the regional as well as global artificial tendons and ligaments market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Application
    • Foot and Ankle Injuries
    • Knee Injuries
    • Shoulder Injuries
    • Others
  • By End users
    • Hospitals and Clinics
    • ASCs
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Artelon
  • Integra Lifesciences Corporation
  • Arthrex, Inc.
  • Stryker Corporation
  • Neoligaments
  • fx solutions
  • Corin Groups
  • Orthomed S.A.S
  • Mathys AG
  • F H Orthopedics
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Knee Injuries

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market share analysis by country

    • 4.3 Shoulder Injuries

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market share analysis by country

    • 4.4 Foot and Ankle Injuries

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market share analysis by country

    • 4.5 Others

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market share analysis by country

  • CHAPTER 5: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Hospitals and Clinics

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market share analysis by country

    • 5.3 ASCs

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market share analysis by country

  • CHAPTER 6: ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Application

      • 6.2.3 North America Market size and forecast, by End users

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Key market trends, growth factors and opportunities
          • 6.2.4.1.2 Market size and forecast, by Application
          • 6.2.4.1.3 Market size and forecast, by End users
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Key market trends, growth factors and opportunities
          • 6.2.4.2.2 Market size and forecast, by Application
          • 6.2.4.2.3 Market size and forecast, by End users
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Key market trends, growth factors and opportunities
          • 6.2.4.3.2 Market size and forecast, by Application
          • 6.2.4.3.3 Market size and forecast, by End users
    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Application

      • 6.3.3 Europe Market size and forecast, by End users

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Key market trends, growth factors and opportunities
          • 6.3.4.1.2 Market size and forecast, by Application
          • 6.3.4.1.3 Market size and forecast, by End users
        • 6.3.4.2 France
          • 6.3.4.2.1 Key market trends, growth factors and opportunities
          • 6.3.4.2.2 Market size and forecast, by Application
          • 6.3.4.2.3 Market size and forecast, by End users
        • 6.3.4.3 UK
          • 6.3.4.3.1 Key market trends, growth factors and opportunities
          • 6.3.4.3.2 Market size and forecast, by Application
          • 6.3.4.3.3 Market size and forecast, by End users
        • 6.3.4.4 Italy
          • 6.3.4.4.1 Key market trends, growth factors and opportunities
          • 6.3.4.4.2 Market size and forecast, by Application
          • 6.3.4.4.3 Market size and forecast, by End users
        • 6.3.4.5 Spain
          • 6.3.4.5.1 Key market trends, growth factors and opportunities
          • 6.3.4.5.2 Market size and forecast, by Application
          • 6.3.4.5.3 Market size and forecast, by End users
        • 6.3.4.6 Rest of Europe
          • 6.3.4.6.1 Key market trends, growth factors and opportunities
          • 6.3.4.6.2 Market size and forecast, by Application
          • 6.3.4.6.3 Market size and forecast, by End users
    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Application

      • 6.4.3 Asia-Pacific Market size and forecast, by End users

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 Japan
          • 6.4.4.1.1 Key market trends, growth factors and opportunities
          • 6.4.4.1.2 Market size and forecast, by Application
          • 6.4.4.1.3 Market size and forecast, by End users
        • 6.4.4.2 China
          • 6.4.4.2.1 Key market trends, growth factors and opportunities
          • 6.4.4.2.2 Market size and forecast, by Application
          • 6.4.4.2.3 Market size and forecast, by End users
        • 6.4.4.3 India
          • 6.4.4.3.1 Key market trends, growth factors and opportunities
          • 6.4.4.3.2 Market size and forecast, by Application
          • 6.4.4.3.3 Market size and forecast, by End users
        • 6.4.4.4 Australia
          • 6.4.4.4.1 Key market trends, growth factors and opportunities
          • 6.4.4.4.2 Market size and forecast, by Application
          • 6.4.4.4.3 Market size and forecast, by End users
        • 6.4.4.5 South Korea
          • 6.4.4.5.1 Key market trends, growth factors and opportunities
          • 6.4.4.5.2 Market size and forecast, by Application
          • 6.4.4.5.3 Market size and forecast, by End users
        • 6.4.4.6 Rest of Asia-Pacific
          • 6.4.4.6.1 Key market trends, growth factors and opportunities
          • 6.4.4.6.2 Market size and forecast, by Application
          • 6.4.4.6.3 Market size and forecast, by End users
    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Application

      • 6.5.3 LAMEA Market size and forecast, by End users

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Brazil
          • 6.5.4.1.1 Key market trends, growth factors and opportunities
          • 6.5.4.1.2 Market size and forecast, by Application
          • 6.5.4.1.3 Market size and forecast, by End users
        • 6.5.4.2 South Africa
          • 6.5.4.2.1 Key market trends, growth factors and opportunities
          • 6.5.4.2.2 Market size and forecast, by Application
          • 6.5.4.2.3 Market size and forecast, by End users
        • 6.5.4.3 Saudi Arabia
          • 6.5.4.3.1 Key market trends, growth factors and opportunities
          • 6.5.4.3.2 Market size and forecast, by Application
          • 6.5.4.3.3 Market size and forecast, by End users
        • 6.5.4.4 Rest of LAMEA
          • 6.5.4.4.1 Key market trends, growth factors and opportunities
          • 6.5.4.4.2 Market size and forecast, by Application
          • 6.5.4.4.3 Market size and forecast, by End users
  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 Arthrex, Inc.

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 fx solutions

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 Orthomed S.A.S

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

    • 8.4 Neoligaments

      • 8.4.1 Company overview

      • 8.4.2 Company snapshot

      • 8.4.3 Operating business segments

      • 8.4.4 Product portfolio

      • 8.4.5 Business performance

      • 8.4.6 Key strategic moves and developments

    • 8.5 Artelon

      • 8.5.1 Company overview

      • 8.5.2 Company snapshot

      • 8.5.3 Operating business segments

      • 8.5.4 Product portfolio

      • 8.5.5 Business performance

      • 8.5.6 Key strategic moves and developments

    • 8.6 Corin Groups

      • 8.6.1 Company overview

      • 8.6.2 Company snapshot

      • 8.6.3 Operating business segments

      • 8.6.4 Product portfolio

      • 8.6.5 Business performance

      • 8.6.6 Key strategic moves and developments

    • 8.7 Mathys AG

      • 8.7.1 Company overview

      • 8.7.2 Company snapshot

      • 8.7.3 Operating business segments

      • 8.7.4 Product portfolio

      • 8.7.5 Business performance

      • 8.7.6 Key strategic moves and developments

    • 8.8 F H Orthopedics

      • 8.8.1 Company overview

      • 8.8.2 Company snapshot

      • 8.8.3 Operating business segments

      • 8.8.4 Product portfolio

      • 8.8.5 Business performance

      • 8.8.6 Key strategic moves and developments

    • 8.9 Integra Lifesciences Corporation

      • 8.9.1 Company overview

      • 8.9.2 Company snapshot

      • 8.9.3 Operating business segments

      • 8.9.4 Product portfolio

      • 8.9.5 Business performance

      • 8.9.6 Key strategic moves and developments

    • 8.10 Stryker Corporation

      • 8.10.1 Company overview

      • 8.10.2 Company snapshot

      • 8.10.3 Operating business segments

      • 8.10.4 Product portfolio

      • 8.10.5 Business performance

      • 8.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 2. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR KNEE INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 3. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR KNEE INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 4. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR SHOULDER INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 5. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR SHOULDER INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 6. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR FOOT AND ANKLE INJURIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 7. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR FOOT AND ANKLE INJURIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 8. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 9. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 10. GLOBAL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 11. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 12. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 13. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR ASCS, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 14. ARTIFICIAL TENDONS AND LIGAMENTS MARKET FOR ASCS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 15. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
    TABLE 16. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 17. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 18. NORTH AMERICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 19. U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 20. U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 21. CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 22. CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 23. MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 24. MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 25. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 26. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 27. EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 28. GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 29. GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 30. FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 31. FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 32. UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 33. UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 34. ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 35. ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 36. SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 37. SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 38. REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 39. REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 40. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 41. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 42. ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 43. JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 44. JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 45. CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 46. CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 47. INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 48. INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 49. AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 50. AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 51. SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 52. SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 53. REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 54. REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 55. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 56. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 57. LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
    TABLE 58. BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 59. BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 60. SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 61. SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 62. SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 63. SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 64. REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
    TABLE 65. REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
    TABLE 66.ARTHREX, INC.: COMPANY SNAPSHOT
    TABLE 67.ARTHREX, INC.: OPERATING SEGMENTS
    TABLE 68.ARTHREX, INC.: PRODUCT PORTFOLIO
    TABLE 69.ARTHREX, INC.: NET SALES
    TABLE 70.ARTHREX, INC.: KEY STRATERGIES
    TABLE 71.FX SOLUTIONS: COMPANY SNAPSHOT
    TABLE 72.FX SOLUTIONS: OPERATING SEGMENTS
    TABLE 73.FX SOLUTIONS: PRODUCT PORTFOLIO
    TABLE 74.FX SOLUTIONS: NET SALES
    TABLE 75.FX SOLUTIONS: KEY STRATERGIES
    TABLE 76.ORTHOMED S.A.S: COMPANY SNAPSHOT
    TABLE 77.ORTHOMED S.A.S: OPERATING SEGMENTS
    TABLE 78.ORTHOMED S.A.S: PRODUCT PORTFOLIO
    TABLE 79.ORTHOMED S.A.S: NET SALES
    TABLE 80.ORTHOMED S.A.S: KEY STRATERGIES
    TABLE 81.NEOLIGAMENTS: COMPANY SNAPSHOT
    TABLE 82.NEOLIGAMENTS: OPERATING SEGMENTS
    TABLE 83.NEOLIGAMENTS: PRODUCT PORTFOLIO
    TABLE 84.NEOLIGAMENTS: NET SALES
    TABLE 85.NEOLIGAMENTS: KEY STRATERGIES
    TABLE 86.ARTELON: COMPANY SNAPSHOT
    TABLE 87.ARTELON: OPERATING SEGMENTS
    TABLE 88.ARTELON: PRODUCT PORTFOLIO
    TABLE 89.ARTELON: NET SALES
    TABLE 90.ARTELON: KEY STRATERGIES
    TABLE 91.CORIN GROUPS: COMPANY SNAPSHOT
    TABLE 92.CORIN GROUPS: OPERATING SEGMENTS
    TABLE 93.CORIN GROUPS: PRODUCT PORTFOLIO
    TABLE 94.CORIN GROUPS: NET SALES
    TABLE 95.CORIN GROUPS: KEY STRATERGIES
    TABLE 96.MATHYS AG: COMPANY SNAPSHOT
    TABLE 97.MATHYS AG: OPERATING SEGMENTS
    TABLE 98.MATHYS AG: PRODUCT PORTFOLIO
    TABLE 99.MATHYS AG: NET SALES
    TABLE 100.MATHYS AG: KEY STRATERGIES
    TABLE 101.F H ORTHOPEDICS: COMPANY SNAPSHOT
    TABLE 102.F H ORTHOPEDICS: OPERATING SEGMENTS
    TABLE 103.F H ORTHOPEDICS: PRODUCT PORTFOLIO
    TABLE 104.F H ORTHOPEDICS: NET SALES
    TABLE 105.F H ORTHOPEDICS: KEY STRATERGIES
    TABLE 106.INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
    TABLE 107.INTEGRA LIFESCIENCES CORPORATION: OPERATING SEGMENTS
    TABLE 108.INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
    TABLE 109.INTEGRA LIFESCIENCES CORPORATION: NET SALES
    TABLE 110.INTEGRA LIFESCIENCES CORPORATION: KEY STRATERGIES
    TABLE 111.STRYKER CORPORATION: COMPANY SNAPSHOT
    TABLE 112.STRYKER CORPORATION: OPERATING SEGMENTS
    TABLE 113.STRYKER CORPORATION: PRODUCT PORTFOLIO
    TABLE 114.STRYKER CORPORATION: NET SALES
    TABLE 115.STRYKER CORPORATION: KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.ARTIFICIAL TENDONS AND LIGAMENTS MARKET SEGMENTATION
    FIGURE 2.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031
    FIGURE 3.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.ARTIFICIAL TENDONS AND LIGAMENTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,BY APPLICATION,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF KNEE INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SHOULDER INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FOOT AND ANKLE INJURIES ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
    FIGURE 17.ARTIFICIAL TENDONS AND LIGAMENTS MARKET,BY END USERS,2021(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF ASCS ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031(%)
    FIGURE 20.ARTIFICIAL TENDONS AND LIGAMENTS MARKET BY REGION,2021
    FIGURE 21.U.S. ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 22.CANADA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 23.MEXICO ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 24.GERMANY ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 25.FRANCE ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 26.UK ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 27.ITALY ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 28.SPAIN ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 29.REST OF EUROPE ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 30.JAPAN ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 31.CHINA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 32.INDIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 33.AUSTRALIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 34.SOUTH KOREA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 35.REST OF ASIA-PACIFIC ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 36.BRAZIL ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 37.SOUTH AFRICA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 38.SAUDI ARABIA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 39.REST OF LAMEA ARTIFICIAL TENDONS AND LIGAMENTS MARKET,2021-2031($MILLION)
    FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 44.COMPETITIVE DASHBOARD
    FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 46.ARTHREX, INC..: NET SALES ($MILLION)
    FIGURE 47.FX SOLUTIONS.: NET SALES ($MILLION)
    FIGURE 48.ORTHOMED S.A.S.: NET SALES ($MILLION)
    FIGURE 49.NEOLIGAMENTS.: NET SALES ($MILLION)
    FIGURE 50.ARTELON.: NET SALES ($MILLION)
    FIGURE 51.CORIN GROUPS.: NET SALES ($MILLION)
    FIGURE 52.MATHYS AG.: NET SALES ($MILLION)
    FIGURE 53.F H ORTHOPEDICS.: NET SALES ($MILLION)
    FIGURE 54.INTEGRA LIFESCIENCES CORPORATION.: NET SALES ($MILLION)
    FIGURE 55.STRYKER CORPORATION.: NET SALES ($MILLION)

Purchase Full Report of
Artificial Tendons and Ligaments Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue